Ardelyx Inc 's ability to collect accounts receivable sequentially worsen to 5.82, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Ardelyx Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 63 days, from 58 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 304 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 1022 to 2268.

What is Receivable Turnover Ratio?
What is Ardelyx Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ARDX Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	78.28 %	24.51 %	44.02 %	67.97 %	65 %
Y / Y Revenue Change	27.47 %	7.82 %	12.3 %	33.38 %	61.04 %
Receivable Turnover Ratio (TTM)	5.82	6.33	6.55	7.02	7.43
ARDX's Total Ranking	# 2268	# 1022	# 1915	# 889	# 319
Accounts Receivable average collection period days	63	58	56	52	49
Seq. Receivable Change	15.3 %	-6.22 %	22.47 %	34.62 %	-19.47 %
Seq. Revenue Change	-24.55 %	13.49 %	12.97 %	31.77 %	-36.18 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 86
Healthcare Sector	# 305
Overall Market	# 2268

Receivable Turnover Ratio Statistics
High	Average	Low
36.98	8.61	1.92
(Dec 31 2018)		(Jun 30 2022)

ARDX Company Profile • Back to ARDX Efficiency Comparisons • Compare ARDX Receivables Turnover Ratio to its Competitors

Financial Statements
Ardelyx Inc 's Accounts Receivable	$ 83 Millions	Visit ARDX's Balance sheet
Ardelyx Inc 's Sales TTM	$ 428 Millions	Visit ARDX's Income Statement
Sources of ARDX's Revenues		Visit ARDX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ARDX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ARDX's Growth Rates	ARDX's Roa	ARDX's Inventory Turnover Ratio	ARDX's Dividend Comparisons
ARDX's Profitability Ratios	ARDX's Roi	ARDX's Asset Turnover Ratio	ARDX's Dividend Growth
ARDX's Valuation Ratios	ARDX's Roe	ARDX's Financial Strength Ratios	ARDX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Nexgel Inc	14.19	$ 10.382 Millions	$ 0.732 Millions
Sutro Biopharma Inc	14.04	$ 99.608 Millions	$ 7.095 Millions
Precipio inc	13.93	$ 25.831 Millions	$ 1.854 Millions
China Pharma Holdings Inc	13.86	$ 3.992 Millions	$ 0.288 Millions
Talkspace Inc	13.67	$ 239.269 Millions	$ 17.501 Millions
Marpai Inc	13.59	$ 17.125 Millions	$ 1.261 Millions
Amneal Pharmaceuticals Inc	13.56	$ 3,045.530 Millions	$ 224.634 Millions
Corcept Therapeutics Inc	13.20	$ 769.096 Millions	$ 58.264 Millions
Xoma Royalty Corporation	13.05	$ 48.555 Millions	$ 3.720 Millions
Mannkind Corporation	13.00	$ 360.783 Millions	$ 27.757 Millions
Lifestance Health Group Inc	12.74	$ 1,494.791 Millions	$ 117.296 Millions
Chemed Corporation	12.73	$ 2,540.548 Millions	$ 199.626 Millions
Milestone Scientific Inc	12.69	$ 8.337 Millions	$ 0.657 Millions
Lftd Partners Inc	12.55	$ 36.955 Millions	$ 2.945 Millions
Clene Inc	12.47	$ 0.134 Millions	$ 0.011 Millions
Skinhealth Systems Inc	12.27	$ 295.223 Millions	$ 24.052 Millions
Cytokinetics Incorporated	12.16	$ 105.815 Millions	$ 8.702 Millions
Precision Biosciences Inc	11.94	$ 45.073 Millions	$ 3.776 Millions
Teladoc Health Inc	11.94	$ 2,514.453 Millions	$ 210.660 Millions
Option Care Health Inc	11.65	$ 5,666.577 Millions	$ 486.439 Millions
Ensysce Biosciences Inc	11.55	$ 4.708 Millions	$ 0.407 Millions
Crinetics Pharmaceuticals Inc	11.52	$ 18.069 Millions	$ 1.569 Millions
Icu Medical Inc	11.46	$ 2,156.379 Millions	$ 188.157 Millions
Nrc Health	11.42	$ 138.642 Millions	$ 12.138 Millions
Nuvation Bio Inc	11.41	$ 142.121 Millions	$ 12.454 Millions
Integrated Biopharma Inc	11.34	$ 47.241 Millions	$ 4.165 Millions
National Healthcare Corp	11.07	$ 1,525.905 Millions	$ 137.813 Millions
Vireo Growth Inc.	11.01	$ 350.469 Millions	$ 31.834 Millions
Bioaffinity Technologies Inc	10.79	$ 5.660 Millions	$ 0.525 Millions
Vivos Therapeutics Inc	10.73	$ 19.092 Millions	$ 1.779 Millions

Date modified: 2026-08-30T14:45:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.